STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease
Authors:
- Anna CzerwoniecACAnna Czerwoniec
- Janusz M. BujnickiJBJanusz M. Bujnicki
- Joanna WesolyJWJoanna Wesoly
- Hans A.R. BluyssenHBHans A.R. Bluyssen
- 1 August 2011
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 22 (4) , 211-219
Abstract
No abstract availableKeywords
Funding Information
- Foundation For Polish Science
- Polish Ministry of Science and Higher Education (N N401 004035, N N302 3312 33, N N302 016339)
- Polish Ministry of Science and Higher Education (0067/P01/2010/70)
This publication has 82 references indexed in Scilit:
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune DiseasesImmunity, 2009
- DOCK 6: Combining techniques to model RNA–small molecule complexesRNA, 2009
- Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivoAtherosclerosis, 2009
- Regulation of interferon and Toll‐like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanismsImmunological Reviews, 2008
- Role of Smooth Muscle Cells in the Initiation and Early Progression of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- STAT-1 decoy oligonucleotide improves microcirculation and reduces acute rejection in allogeneic rat small bowel transplantsGene Therapy, 2007
- Evidence for licensing of IFN-γ-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction programProceedings of the National Academy of Sciences, 2006
- Inflammation in atherosclerosisNature, 2002
- IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.Journal of Clinical Investigation, 1998